YHLO Showcased Its Latest iFlash CLIA at MEDICA 2021



From 15-18 November, YHLO is making a grand exposure at MEDICA 2021, with its latest  chemiluminescence immunoassay (CLIA) analyzer iFlash 1200, the bench-top analyzer iFlash 1800, the mono-test CLIA analyzer iStar 500, and total solutions for SARS-CoV-2 on exhibition.


With more than 40 years of history, MEDICA is recognized as the world's largest medical trade fair covering virtually every aspect of the medical industry including outpatient clinic, emergency aid, clinical treatment, home/remote care, laboratory science and so on. It has attracted reputable businesses and experts from around the world each year.


YHLO iFlash 1200 has captured waves of visitors at MEDICA site, who are impressed by the convenience of fully automation for clinical diagnostics. iFlash 1200 offers an unparalleled workstation to the low-mid volume testing laboratories. As its name,  iFlash means more than a CLIA analyzer, which offers the following advantages:

  • Intelligent—with reflex, auto-dilution and auto rerun function, it provides predictable results delivery time.

  • Flexible—with a broader assay menu, it requires less outsourcing for laboratories and hospitals.

  • Liberate—the automated reaction vessels loading and continuous reagent and sample loading can liberate the laboratory operators from the repetitive work.

  • Accurate—with stable temperature control system, non-contact vortex mixer that will minimize carry-over, it offers more accurate results.

  • Smaller—as a consolidation with 120 parameters, it takes shape as a compact size.

  • Harmonious—the reagents and consumables are compatible with the original iFlash series.


With the extensive and expanding immunoassay testing menu—more than 120 parameters available covering autoimmunity, fertility, infection, COVID-19, etc.—iFlash 1200 satisfies the routine needs of small to medium sized laboratories.


iStar 500, a highly-automated mono-test CLIA analyzer manufactured by Drawray—a YHLO subsidiary brand—is an ideal choice for small to medium labs with less sample volume. It can be widely used in emergency diagnosis as its compact, integrated workflow,  single-test design and comprehensive test panels.


YHLO has also showcased its total solutions for SARS-CoV-2 menus, which include antibody, antigen and neutralizing antibody tests based on CLIA and POCT platforms.


More demos of YHLO solutions are presented at YHLO booth – 1D15 – at MEDICA 2021 from November 15-18, in Dusseldorf. For more information, please contact marketing@szyhlo.com.


Join Us



Headquarter: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China

Follow YHLO

wechatwechat wechat wechat wechat

© 2020  Shenzhen YHLO Biotech Co., Ltd.  All rights reserved.  粤ICP备17105123号